KeyCorp director granted 7,352 deferred share units
KEYCORP director Christopher L. Henson reported a compensation-related award of 7,352 Deferred Shares.
Rhea-AI Filing Summary
KEYCORP director Christopher L. Henson reported a compensation-related award of 7,352 Deferred Shares. These Deferred Shares are economically equivalent to the company’s Common Shares and were granted under KeyCorp’s Amended and Restated Directors’ Deferred Share Sub-Plan of the KeyCorp 2026 Equity Compensation Plan.
Under the plan, Henson is scheduled to receive payment of the 7,352 Deferred Shares one-half as Common Shares and one-half in cash on May 14, 2029. Following the transactions reported, he also holds 250 Common Shares directly. The filing reflects a grant/award acquisition, not an open-market purchase or sale.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Deferred Shares | 7,352 | $0.00 | $0.00 |
| holding | Common Shares | -- | -- | -- |
Footnotes (3)
- F1. Each Deferred Share is the economic equivalent of one Common Share.
- F2. Under the terms of KeyCorp's Amended and Restated Directors' Deferred Share Sub-Plan of the KeyCorp 2026 Equity Compensation Plan (the "Deferred Share Plan"), the Participant will receive payment of the Deferred Shares one-half as Common Shares and one-half in cash on May 14, 2029.
- F3. The Deferred Shares were awarded under the Deferred Share Plan.
Key Figures
Key Terms
KeyCorp 2026 Equity Compensation Plan financial
grant/award acquisition financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did KEY (KeyCorp) director Christopher L. Henson report in this Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.